Q4 2023 Arcutis Biotherapeutics Inc Earnings Call Transcript
Good day and welcome to the Arcutis Biotherapeutics 2023 Fourth Quarter and Full Year financial results conference call. (Operator Instructions) Once again, please be advised that today's conference is being recorded. I would now like to hand the call over to Derek Cole, Arcutis Investor Relations. Please go ahead.
Thank you, Andrew. Good morning, everyone, and thank you for joining us today to review 2023 financial results and a business update slides for today's call are available on the investor section of the Arcutis website.
On the call today, we have Frank Watanabe, President and CEO; Patrick Burnett, Chief Medical Officer; Todd Edwards, Chief Commercial Officer; and John Smither, Chief Financial Officer.
I'd remind everyone that we will be making forward-looking statements during this call. These statements are subject to certain risks and uncertainties, and our actual results may differ. So we encourage you to review all the company's filings with the Securities and Exchange Commission,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |